The mitochondrial targeting of the MUC1-C was found to be triggered by Heregulin, a ligand for Erbb2-4, because both MUC1 and HER2 were found to be co-expressed in stage II and III CRC [119]. Here, ERBB2 is linked to colorectal carcinoma.